Patents by Inventor Allison Ebert

Allison Ebert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In Vitro Model Of Spinal Muscular Atrophy
    Publication number: 20120264648
    Abstract: A population of iPS cells derived from somatic cells from a spinal muscular atrophy patient is disclosed. In one embodiment of the invention, the cells have been cultured to produce neural cells. In another embodiment, the invention is a method of testing compounds for their ability to modify cellular SMN levels comprising the steps of obtaining a population of iPS cells derived from a spinal muscular atrophy patient or cells derived from the iPS cells, and examining the effect of a test compound on SMN levels.
    Type: Application
    Filed: April 19, 2012
    Publication date: October 18, 2012
    Inventors: Clive Svendsen, Allison Ebert
  • In vitro model of spinal muscular atrophy
    Patent number: 8211631
    Abstract: A population of iPS cells derived from somatic cells from a spinal muscular atrophy patient is disclosed. In one embodiment of the invention, the cells have been cultured to produce neural cells. In another embodiment, the invention is a method of testing compounds for their ability to modify cellular SMN levels comprising the steps of obtaining a population of iPS cells derived from a spinal muscular atrophy patient or cells derived from the iPS cells, and examining the effect of a test compound on SMN levels.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: July 3, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Clive Svendsen, Allison Ebert
  • In vitro model of spinal muscular atrophy
    Publication number: 20100279893
    Abstract: A population of iPS cells derived from somatic cells from a spinal muscular atrophy patient is disclosed. In one embodiment of the invention, the cells have been cultured to produce neural cells. In another embodiment, the invention is a method of testing compounds for their ability to modify cellular SMN levels comprising the steps of obtaining a population of iPS cells derived from a spinal muscular atrophy patient or cells derived from the iPS cells, and examining the effect of a test compound on SMN levels.
    Type: Application
    Filed: December 18, 2009
    Publication date: November 4, 2010
    Inventors: Clive Svendsen, Allison Ebert